TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Vital capacity maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Infant Pain Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRR‐1 following maximal arm‐ergometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients exhibiting a complete response (no retching or vomiting for 24 h)
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of edema
Endpoint domain: Adverse events/effects
Primary endpoint: Early study discontinuations due to edema
Endpoint domain: Adverse events/effects
Primary endpoint: Edema-related symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants administering benzodiazepines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants administering or titrating opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preparedness and advance care planning
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Performance on NT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GR‐GRE binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMN-Elastase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality-Adjusted Life Years (QALY)
Endpoint domain: Resource use
Primary endpoint: Incremental Cost-Effectiveness Ratio (ICER)
Endpoint domain: Resource use
Primary endpoint: Incidence and severity of myalgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of LH, PRL and T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Abstinence from substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOC score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hidradenitis suppurativa clinical response at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to a new HS exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (KOOS) assessment of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total cholesterol (TC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid profiles
Primary endpoint: Low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid profiles
Primary endpoint: Good outcomes (moderate, mild, or no disabilities)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relative knee flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Self-reported vigorous-intensity physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in %LRNC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: anastomotic leaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BVMT-R Learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: Ease of use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Instructions understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BDI total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Evaluation of Disability Inventory mobility functional skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility caregiver assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐care caregiver scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for colonoscopy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased mammographic breast density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast tenderness
Endpoint domain: Adverse events/effects
Primary endpoint: Appropriate cancer referrals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Travel time to appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Travel costs to appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: age-adjusted posttreatment clinical response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin sensitivity (GIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of significant grey-scale changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sonication time to reach massive grey-scale changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sonication time for ablating 1 cm3 of fibroid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular concentrations of ESBA105
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum CT-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary Artery Calcium (CAC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of loss of sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of loss of sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak inspiratory pressure (PIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ankle-rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Olerud and Molander ankle score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial hemostasis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: Permanent hemostasis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total active motion of the distal finger joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with excellent/good digit mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tip-to-crease distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total volume of urine passed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Peak urinary 19-NA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to peak urinary 19-NA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Antibody responses to pertussis antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean/concentrations of antibodies to Hib and HBV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in IBS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in purchase of red-labelled beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in consumption of red-labelled beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in eating disorder cognitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in dietary restraint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in eating in response to negative affect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rehospitalization due to worsening heart failure
Endpoint domain: Adverse events/effects
Primary endpoint: Need for mechanical ventilation or death within 7 days of age
Endpoint domain: Mortality/survival
Primary endpoint: Need for mechanical ventilation before discharge
Endpoint domain: Mortality/survival
Primary endpoint: Perceived trust in the provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Active recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competence in performing CPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy in implant positions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median time to recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first inappropriate ICD therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: proteinuria prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 3-year mortality associated with proteinuria
Endpoint domain: Mortality/survival
Primary endpoint: Reversal of small dense LDL phenotype (LDL pattern B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Psychological distress (anxiety and depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adaptive IBS related behavioral coping
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: consistent condom use rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in plasma NPY, ET, and ANP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: LDL-C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in serum K+ at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with hyperkalaemia (K+ >5.5 mEq/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion titrated to spironolactone 50 mg/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant adherence to the programme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substantial benefits reported by participants after follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: organization
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: disruptive behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: homework performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: grades
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mean abuse scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical wellbeing mean scores (PCS-SF36)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mental wellbeing mean scores (MCS-SF36)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fructosamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: whole blood GSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hsCRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correct positioning of catheters in the SVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success rate of implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in Periotest values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of IGT to type 2 diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sense of meaning and acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vit.D serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance (CL) of total and unbound cisplatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma carnitine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in pain immediately after stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for nasal crusting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total nasal resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appeal of smoking products
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Taste of smoking products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoothness on the throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: %BF (body fat percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAT (visceral adipose tissue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean peak plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean terminal disposition half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal AChE inhibition (Emax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Weight Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid and electrolyte events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected visual acuity of 6/18 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corrected postoperative vision of 6/18 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tender joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swollen joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target lesion patency at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentrations of homocysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma concentrations of AdoHcy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Portal pressure gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall perceptions of patient safety culture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Need for additional analgesia medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: continuously abstinent rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enamel surface roughness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hardness values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CGI-Severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CGI-Improvement score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean pain score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: intraoperative bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Endurance Time to Exhaustion (ETE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood FFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Peripheral resistance reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Virological suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relief of symptoms of fatigue or low energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relaxation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma perhexiline concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in alcohol problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in heavy drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroma magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroma duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of evacuative punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myelosuppression
Endpoint domain: Adverse events/effects
Primary endpoint: Labelling score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient knowledge score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular responsiveness to NTG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Bioconversion of NTG to glyceryl dinitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generation of O(2)(‐)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis sensitivity of preeclampsia CI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of preeclampsia CI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the ROC curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep resistance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: sleep dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: sleep anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: coefficient of fat absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: coefficient of nitrogen absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: short- or long-term abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful eruption of the maxillary canines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and course of renal function of CIN after CAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of renal artery stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mortality from microbiologically and clinically documented fungal infection
Endpoint domain: Mortality/survival
Primary endpoint: complete resolution of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: processing of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to remain awake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with complete sensory blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of conjunctivitis
Endpoint domain: Adverse events/effects
Primary endpoint: Gross Motor Function Measure-88
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes